Advertisement

Topics

Clinical trial fails to disclose risk of death, repeat heart attacks, group says

21:30 EDT 1 Aug 2017 | Topix

Mount Sinai Medical Center in Miami Beach is one of dozens of hospitals across the country selected to participate in the Myocardial Ischemia and Transfusion or MINT trial, a clinical trial sponsored by the National Institutes of Health to test blood transfusion therapies for heart attack patients with anemia. A nonprofit consumer advocacy group, Public Citizen, has asked federal regulators to suspend enrollment in the MINT trial, calling the study unethical because it fails to inform patients of the risk of death or repeat heart attacks.

Original Article: Clinical trial fails to disclose risk of death, repeat heart attacks, group says

NEXT ARTICLE

More From BioPortfolio on "Clinical trial fails to disclose risk of death, repeat heart attacks, group says"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...